| Literature DB >> 11165970 |
A Roguin1, I Hochberg, E Nikolsky, W Markiewicz, S R Meisel, J Hir, E Grenadier, R Beyar, A P Levy.
Abstract
We have demonstrated that a genetic polymorphism in the antioxidant protein haptoglobin is important in determining which patients develop restenosis after percutaneous transluminal coronary angioplasty. Knowledge of the haptoglobin phenotype may be useful in the assessment and utilization of new therapies to reduce restenosis, particularly in patients who are homozygous for the haptoglobin 2 allele.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11165970 DOI: 10.1016/s0002-9149(00)01368-0
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778